XENE insider trading
Open-market stock trades by Xenon Pharmaceuticals (XENE) executives and directors: who bought or sold, how many shares, at what price and when.
XENE insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Kelly Thomas Patrick | Chief Financial Officer | Buy | 15,000 | $37.32 | $559.74K |
| Sep 30, 2026 | MORTIMER IAN | PRESIDENT & CEO | Buy | 30,000 | $37.38 | $1.12M |
| Aug 28, 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | Sell | 6,368 | $60.17 | $383.15K |
| Aug 28, 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | Sell | 700 | $60.98 | $42.68K |
| Aug 11, 2026 | GANNON STEVEN | director | Sell | 10,000 | $64.06 | $640.55K |
| Jun 5, 2026 | PATOU GARY | director | Sell | 1,322 | $53.14 | $70.25K |
| Jun 5, 2026 | Cannon Gillian | director | Sell | 1,190 | $53.14 | $63.24K |
| Mar 13, 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | Sell | 1,410 | $55.23 | $77.87K |
| Mar 13, 2026 | DiFabio Andrea | Chief Legal Officer | Sell | 1,342 | $55.23 | $74.11K |
| Mar 13, 2026 | MORTIMER IAN | PRESIDENT & CEO | Sell | 7,308 | $55.23 | $403.58K |
| Mar 10, 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | Sell | 2,771 | $60.11 | $166.56K |
| Mar 10, 2026 | DiFabio Andrea | Chief Legal Officer | Sell | 2,607 | $60.11 | $156.70K |
| Mar 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | Sell | 43,348 | $59.26 | $2.57M |
| Mar 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | Sell | 21,791 | $58.81 | $1.28M |
| Mar 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | Sell | 31,694 | $59.88 | $1.90M |
| Mar 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | Sell | 12,479 | $59.50 | $742.50K |
| Mar 10, 2026 | MORTIMER IAN | PRESIDENT & CEO | Sell | 11,269 | $60.11 | $677.36K |
| Mar 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | Sell | 10,072 | $60.47 | $609.05K |
| Mar 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | Sell | 65,000 | $62.06 | $4.03M |
| Mar 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | Sell | 2,449 | $61.26 | $150.03K |
| Mar 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | Sell | 61,652 | $60.08 | $3.70M |
| Mar 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | Sell | 21,515 | $60.49 | $1.30M |
| Jan 2, 2026 | MORTIMER IAN | PRESIDENT & CEO | Sell | 37,938 | $44.40 | $1.68M |
| Jan 2, 2026 | MORTIMER IAN | PRESIDENT & CEO | Sell | 2,062 | $44.93 | $92.65K |
| Dec 5, 2025 | MORTIMER IAN | PRESIDENT & CEO | Sell | 14,375 | $45.03 | $647.31K |
| Dec 8, 2025 | MORTIMER IAN | PRESIDENT & CEO | Sell | 8,820 | $45.59 | $402.10K |
| Dec 8, 2025 | MORTIMER IAN | PRESIDENT & CEO | Sell | 2,010 | $46.32 | $93.10K |
| Nov 28, 2025 | MORTIMER IAN | PRESIDENT & CEO | Sell | 97 | $45.01 | $4.37K |
- XENE insiders bought $1.68M and sold $21.97M in open-market trades over their last 28 filings.
Updated 2026-11-02 23:12 UTC